Hormone receptor-positive (HR+)
Breast cancer cells that have either oestrogen receptors, or progesterone receptors, or oestrogen and progesterone receptors.
Breast cancer cells that have either oestrogen receptors, or progesterone receptors, or oestrogen and progesterone receptors.
Roche does not endorse or control, the content of any linked websites and if you click on any of those links you agree that Roche has no responsibility or duty to you for anything that happens to you as a result. If the linked site is outside New Zealand’s jurisdiction, the information may not be consistent with New Zealand’s legislation, advertising codes or the relevant New Zealand registered Data Sheet.
Please refer to the Data Sheet or Consumer Medicine Information on the Medsafe website for product information applicable to New Zealand.
Click OK to continue.
Ok Continue Close